The 20 Best Bone Tumor Doctors Near Me in Ann Arbor, MI

Scott Schuetze is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Schuetze is rated as a Distinguished provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Liposarcoma, Adult Soft Tissue Sarcoma, Angiosarcoma, and Myxoid Liposarcoma.

Rashmi Chugh is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Chugh is rated as a Distinguished provider by MediFind in the treatment of Bone Tumor. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Ganglioneuroblastoma, Rhabdomyosarcoma, Rhabdoid Tumor Predisposition Syndrome, and Rhabdoid Tumor.

Dr. Biermann serves as Director of the Musculoskeletal Oncology Program at the University of Michigan. Her clinical interests include malignant and benign tumors of soft tissue and bone, both primary and metastatic. Her practice includes both adults and children. Dr. Biermann chairs the Multidisciplinary Sarcoma Tumor Board, a collaborative cancer center group including medical and pediatric oncologists, pathologist, diagnostic radiologists, and radiation therapists. The Sarcoma clinic meets weekly. The University of Michigan Sarcoma team engages in patient care, clinical trials, and basic science research. In addition to her regional responsibilities, Dr. Biermann has been active in national committee and administrative work. She chairs the National Comprehensive Cancer Network (NCCN) Bone Tumors Panel. She is past president of the Musculoskeletal Tumor Society (MSTS). She is a member of the American Society of Clinical Oncology (ASCO). She sits on the Orthopaedic Research and Education Foundation (OREF) Grant Board. Her active research program has included more than 87 publications in the areas of musculoskeletal tumors and in the impact of the Internet on patient education. Dr. Biermann is the University of Michigan Medical Director for the Sarcoma Program and the Orthopaedic Surgery Residency Program Director. Dr. Biermann is rated as a Distinguished provider by MediFind in the treatment of Bone Tumor. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Ewing Sarcoma, Bone Tumor, Chondrosarcoma, Osteosarcoma, and Hip Replacement. Dr. Biermann is board certified in Orthopedic Surgery.

Dr. Geoffrey Siegel is a Michigan native who received his Medical Doctorate Degree at the Detroit Medical Center and his residency in Orthopaedic Surgery at Wayne State University. After finishing his fellowship in Orthopaedic Oncology at Vanderbilt University Medical Center in Nashville, Tennessee, he joined the Department of Orthopaedic Surgery at the University of Michigan as Clinical Assistant Professor.Dr. Siegel's clinical interests are in the treatment of benign and malignant disease, both metastatic as well as primary bone cancer in adults and children. His surgical interests include limb salvage and complex musculoskeletal reconstruction. He enjoys both resident and community physician education in the field of Musculoskeletal Oncology. Dr. Siegel is rated as a Distinguished provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Bone Tumor, Chondrosarcoma, Epithelioid Sarcoma, and Hip Replacement. Dr. Siegel is board certified in Orthopedic Sports Medicine and Orthopedic Surgery.

Dr. Cuneo grew up in Northern California. He studied Biological and Environmental Engineering at Cornell University in Ithaca, NY. Dr. Cuneo received his Doctor of Medicine degree from Vanderbilt University School of Medicine in 2007 and completed an internship there in 2008. In 2008 he started his residency in Radiation Oncology at Duke University Medical Center. Dr. Cuneo has been an Assistant Professor in the Department of Radiation Oncology at the University of Michigan since 2012. Dr. Cuneo is rated as a Distinguished provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Pancreatic Cancer, Liposarcoma, Liver Cancer, and Pancreaticoduodenectomy. Dr. Cuneo is board certified in Radiation Oncology.

Rama Rao is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Rao is rated as an Advanced provider by MediFind in the treatment of Bone Tumor. She is also highly rated in 36 other conditions, according to our data. Her clinical expertise encompasses Osteosarcoma, Chondrosarcoma, Hereditary Neuroblastoma, Neuroblastoma, and Bone Marrow Aspiration. Dr. Rao is board certified in Pediatric Hematology-Oncology.

Dr. Nick Szerlip is originally from New York, just north of Manhattan, but lived many places around the country while growing up. He attended Columbia University for his undergraduate studies, where he obtained a bachelor’s degree in psychology. He then attended Tulane University School of Medicine in New Orleans, where he obtained his medical degree. After graduating medical school, Dr. Szerlip completed his residency training at the University of Maryland in Baltimore.Dr. Szerlip obtained additional fellowship training during a fellowship at the National Institutes of Health (NIH), where he examined the origins of cancer cells and effective drug delivery to treat cancer, followed by a fellowship in neurosurgical oncology at Memorial Sloan Kettering Cancer Center in New York. The direction of his neurosurgical career has largely been shaped by the loss of his mother to metastatic cancer in the early part of his neurosurgery residency. Her legacy drives him to be a better physician, to search for a solution to spine cancer, and to train future neurosurgeons to approach their patients with the skill, compassion, and respect they deserve during a very difficult time.Clinically, Dr. Szerlip treats disorders of the spine including arthritis, malalignment and specializes in surgical and radiation treatment of spine tumors. His goal at the University of Michigan is to continue to build a clinical and translational spine oncology program that will enable the clinic and the laboratory to work together as partners to rapidly advance care for spine cancer. This model will foster synergy among physicians and researchers, affording our patients access to the latest clinical trials and outstanding, compassionate care; it will also accelerate new therapies for future patients. Dr. Szerlip is rated as an Advanced provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Bone Tumor, Hemangioblastoma, Fractured Spine, Laminectomy, and Microdiscectomy. Dr. Szerlip is board certified in Neurological Surgery.

Dr. Lesly Dossett, MD, MPH, is the Maud T. Lane Research Professor for Cancer Quality Improvement and Chief of the Division of Surgical Oncology at the University of Michigan. Dr. Dossett earned her medical degree from Vanderbilt University School of Medicine in 2003, having attended on a United States Navy Health Professions Scholarship. She completed her general surgery residency at Vanderbilt University in 2010, which included a health services research fellowship and completion of an MPH. After residency, Dr. Dossett served on active duty with the United States Navy in several roles stateside and overseas, including completing two deployments supporting combat operations in Afghanistan. After leaving the Navy in 2014, Dr. Dossett completed a clinical fellowship in Complex General Surgical Oncology at Moffitt Cancer Center and joined the faculty of the University of Michigan in 2016.Dr. Dossett specializes in treating patients with melanoma, soft tissue sarcoma, and breast cancer. Her research leverages implementation science frameworks and behavioral strategies to improve healthcare value. As co-director of the Michigan Program for Value Enhancement (MPrOVE), she works to translate value-based research findings into practice at Michigan Medicine and then scale those strategies more broadly to hospitals and healthcare systems. She is a principal investigator for R01s funded by the National Cancer Institute (NCI) and the Agency for Healthcare Research and Quality (AHRQ). She serves as a mentor on several federally funded training grants and career development awards.Dr. Dossett is an active member of several national societies. She serves as an officer in the Association for Academic Surgeons (AAS) and in the executive leadership of the American College of Surgeons (ACS) Cancer Research Program (CRP) and the Surgical Outcomes Club.Clinical Specialization:Dr. Dossett’s clinical focus is on melanoma and non-melanoma skin cancers, sarcoma, and breast cancer. She has expertise in locally and regionally advanced melanoma, breast angiosarcoma, retroperitoneal and pelvic sarcoma, breast conservation therapy, and skin and nipple sparing mastectomy. Dr. Dossett is rated as an Advanced provider by MediFind in the treatment of Bone Tumor. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Retroperitoneal Liposarcoma, Melanoma, Desmoplastic Small Round Cell Tumor, Mastectomy, and Lymphadenectomy. Dr. Dossett is board certified in Surgery and Complex General Surgical Oncology.

Dr. Angeles is an Associate Professor with Tenure of Surgery, Associate Professor of Dermatology, and Faculty Member in the Cancer Biology PhD Program at the University of Michigan in the Division of Surgical Oncology. She earned her medical degree at Tufts University School of Medicine. She completed general surgery residency at New York Presbyterian-Weill Cornell Medical Center. While in residency she completed a two-year basic/translational science Surgical Oncology Research Fellowship at Memorial Sloan-Kettering Cancer Center (MSKCC) focusing on the molecular biology and novel therapeutics for sarcoma. After residency, Dr. Angeles returned to MSKCC and completed a clinical Complex Surgical Oncology Fellowship. Dr. Angeles is board-certified in both General Surgery and Complex General Surgical Oncology. She is the Director of the Regional Cancer Therapies Clinic at University of Michigan/Rogel Cancer Center. Dr. Angeles is a nationally recognized surgeon-scientist dedicated to advancing cancer care through innovative research and compassionate patient care. As the lead investigator for multiple clinical trials at the Rogel Cancer Center, she is at the forefront of developing new treatments for melanoma and sarcoma. Her laboratory studies the immune system’s role in fighting cancer, with a special focus on how resident memory T cells can help create long-lasting protection against tumors. By combining basic science and translational research, Dr. Angeles and her team are working to transform discoveries in the lab into effective new therapies for patients. Dr. Angeles’s research has been supported by the American Cancer Society, the Melanoma Research Alliance, the Society of Surgical Oncology, and the National Institutes of Health’s National Cancer Institute (NCI-NIH).Committed to excellence in both science and patient care, Dr. Angeles is a Fellow of the American College of Surgeons, a Fellow of the Society of Surgical Oncology, and an active member of professional societies including the American Society of Clinical Oncology (ASCO), the Society of Surgical Oncology (SSO), the Connective Tissue Oncology Society (CTOS), and the Society for Immunotherapy of Cancer (SITC). She also serves as Chair of the Society of Surgical Oncology's Research Committee, helping to shape the future of cancer research and treatment.Clinical Specialization:Dr. Angeles is a board-certified surgical oncologist whose clinical practice focuses on patients with soft tissue cancers including sarcoma, melanoma, and non-melanoma cutaneous malignancies. Dr. Angeles cares for patients in a robust multidisciplinary fashion and provides education and counseling to her patients in order to allow shared decision making for the surgical management of their disease. Dr. Angeles is rated as an Advanced provider by MediFind in the treatment of Bone Tumor. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Liposarcoma, Adult Soft Tissue Sarcoma, Melanoma, Splenectomy, and Nephrectomy. Dr. Angeles is board certified in Surgery and Complex General Surgical Oncology.

Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is rated as an Advanced provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology.

Dr. Hearn is an Associate Professor in the Department of Radiation Oncology at the University of Michigan. He completed his medical training at Harvard Medical School and his residency in radiation oncology at Cleveland Clinic. Dr. Hearn investigates mechanisms by which prostate cancer may become resistant to current treatments.Dr. Hearn also treats bladder cancer and has been impressed by the promising responses (sometimes dramatic and long-lasting) that some patients with bladder cancer have when treated with immunotherapy to harness the body’s immune system. He is interested in the intersection of immunotherapy and radiation therapy.Additionally, Dr. Hearn is interested in novel techniques to improve the safety and efficacy of radiation therapy for lung cancer by modulating cytokines relevant to lung injury. Dr. Hearn is rated as an Advanced provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, Muscle Invasive Bladder Cancer, and Prostatectomy. Dr. Hearn is board certified in Radiation Oncology.

Victoria Wytiaz is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Wytiaz is rated as an Advanced provider by MediFind in the treatment of Bone Tumor. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Desmoid Tumor, Bone Tumor, Synovial Sarcoma, and Rhabdoid Tumor. Dr. Wytiaz is board certified in Pediatrics, Medical Oncology, and Internal Medicine.

Mario Lacerna is a Radiation Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Lacerna is rated as an Experienced provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Breast Cancer. Dr. Lacerna is board certified in Radiation Oncology.

Terri Bott-Kothari, MD has been in practice for over 16 years treating all disease sites. She completed her medical training at Wayne State University School of Medicine and residency at the University of Cincinnati. Dr. Bott is rated as an Experienced provider by MediFind in the treatment of Bone Tumor. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Pleuropulmonary Blastoma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Familial Prostate Cancer. Dr. Bott is board certified in Radiation Oncology.

Mary Mcgrath is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Mcgrath is rated as an Experienced provider by MediFind in the treatment of Bone Tumor. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Factor 11 Deficiency, Hemophilia A, Hemophilic Arthropathy, and Glanzmann Thrombasthenia. Dr. Mcgrath is board certified in Pediatric Hematology-Oncology and Pediatrics.

Hugh Garton is a Neurosurgery provider practicing medicine in Ann Arbor, Michigan. Dr. Garton is rated as an Experienced provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 72 other conditions, according to our data. His clinical expertise encompasses Chiari Malformation, Chiari Malformation Type 1, Chiari Malformation Type 2, Posterior Fossa Decompression, and Gamma Knife Radiosurgery. Dr. Garton is board certified in Neurological Surgery.

David Svilar is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Svilar is rated as an Experienced provider by MediFind in the treatment of Bone Tumor. His clinical expertise encompasses Sickle Cell Disease, Hereditary Spherocytosis, Febrile Neutropenia, and Shwartzman Phenomenon. Dr. Svilar is board certified in Pediatric Hematology-Oncology and Pediatrics.

Laurence Baker is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Baker is rated as an Advanced provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Ewing Sarcoma, Osteosarcoma, and Bone Tumor.

Dr. Jackson is an Assistant Professor in the Department of Radiation Oncology at the University of Michigan. He performed his residency in radiation oncology at the University of Michigan, and subsequently joined the faculty upon completion of his training. Within the Department of Radiation Oncology, he serves as the co-Chief of the Genitourinary Radiotherapy Program. Within the Rogel Cancer he is the co-Director of the multidisciplinary Spine Oncology Program.Dr. Jackson’s research focuses mainly on improving outcomes for men with aggressive or recurrent prostate cancer, and he has published extensively on this topic. Dr. Jackson is rated as an Advanced provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Penile Cancer. Dr. Jackson is board certified in Radiation Oncology.

Shruti Jolly MD is an Associate Professor and Associate Chair of Community Practices in the Department of Radiation Oncology at the University of Michigan. She received her undergraduate and medical degrees at Wayne State University as a Presidential Scholar. In 2007, she completed her medical training at William Beaumont Hospital in Royal Oak, Michigan where she served as chief resident and received the RSNA Roentgen Resident Research Award. Dr. Jolly then joined the faculty at the University of Michigan Department of Radiation Oncology. Dr. Jolly directs the treatment of thoracic, gynecologic and endocrine malignancies. She also serves as the director of Brachytherapy, specializing in High Dose Rate (HDR) brachytherapy procedures. Additionally, she is the principal investigator of numerous clinical protocols designed to individualize the radiation therapy of lung and gynecologic cancer patients. Dr. Jolly has authored numerous publications in peer-reviewed journals. As Associate chair of Community Practices, she oversees the standardization and quality of care of patients receiving radiation therapy at the numerous UM Radiation Oncology community practices across the state of Michigan. In addition she also serves as a consultant for the Michigan Radiation Oncology Quality Consortium (MROQC) focused on quality improvement in patients undergoing radiation therapy for breast cancer, lung cancer and bone metastases. Dr. Jolly is rated as an Experienced provider by MediFind in the treatment of Bone Tumor. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Adrenal Cancer, and Pleuropulmonary Blastoma. Dr. Jolly is board certified in Radiation Oncology.